Indeed, as proof of the validity of our method, we identified many genes that are known to be differentially methylated across various cancer types (CDKN2A, CDKN2B, MGMT, SFRP1), in addition to many novel genes not previously known to be regulated by DNA methylation. The gene discussed is CDKN2B; the disease is cancer.